Moving towards personalized care: liquid biopsy predicts response to cisplatin in an unusual case of BRCA2-null neuroendocrine prostate cancer
Chedgy, Edmund CP., Annala, Matti, Beja, Kevin, Warner, Evan W., Gleave, Martin E., Chi, Kim N., Wyatt, Alexander W.Language:
english
Journal:
Clinical Genitourinary Cancer
DOI:
10.1016/j.clgc.2015.12.023
Date:
December, 2015
File:
PDF, 1.14 MB
english, 2015